| 000 | 00794nmm a2200253Ia 4500 | ||
|---|---|---|---|
| 008 | 140908s9999 xx 000 0 und d | ||
| 020 | _a9783540495291, 978-3-540-49529-1 | ||
| 040 | _aNISER LIBRARY | ||
| 041 | _aEnglish | ||
| 082 |
_a615, _b23 |
||
| 245 | _aAppropriate Dose Selection-How to Optimize Clinical Drug Development | ||
| 260 |
_aBerlin, Heidelberg _bSpringer Berlin Heidelberg _c2007. |
||
| 500 | _aBiomedical and Life Sciences (Springer-11642) | ||
| 650 | _aBiochemistry, general | ||
| 650 | _aMedicine/Public Health, general | ||
| 650 | _aBiochemistry | ||
| 650 | _aBiomedicine | ||
| 650 | _aMedicine | ||
| 650 | _aPharmacology/Toxicology | ||
| 650 | _aToxicology | ||
| 700 | _aVenitz, J. | ||
| 856 | _uhttp://dx.doi.org/10.1007/978-3-540-49529-1 | ||
| 942 | _cEB | ||
| 999 |
_c18173 _d18173 |
||